Search hospitals > Ohio > Cleveland
Hillcrest Hospital Cancer Center
Claim this profileCleveland, Ohio 44124
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Ovarian Cancer
Conducts research for Adenocarcinoma
Conducts research for Breast Cancer
235 reported clinical trials
34 medical researchers
Summary
Hillcrest Hospital Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Breast Cancer and other specialties. Hillcrest Hospital Cancer Center is involved with conducting 235 clinical trials across 278 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, Nathan A. Pennell, Dale Shepard, and Aaron Gerds, MD, MS.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
Stage III
Stage I
Top PIs
Peter Rose, MDCleveland Clinic Foundation1 year of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
25 reported clinical trials
50 drugs studied
Nathan A. PennellCleveland Clinic Foundation2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
25 drugs studied
Dale ShepardCleveland Clinic Foundation7 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
38 drugs studied
Aaron Gerds, MD, MSCleveland Clinic Foundation4 years of reported clinical research
Studies Myelofibrosis
Studies Primary Myelofibrosis
11 reported clinical trials
17 drugs studied
Clinical Trials running at Hillcrest Hospital Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Colorectal Cancer
Squamous Cell Carcinoma
Ovarian Cancer
Oropharyngeal Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hillcrest Hospital Cancer Center?
Hillcrest Hospital Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Breast Cancer and other specialties. Hillcrest Hospital Cancer Center is involved with conducting 235 clinical trials across 278 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, Nathan A. Pennell, Dale Shepard, and Aaron Gerds, MD, MS.